Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages

被引：4

作者：

Ly, Andrew ^{[1
]}

Sanber, Khaled ^{[2
]}

Tsai, Hua-Ling ^{[2
]}

Ondo, Angela ^{[2
]}

Mooney, Kathy ^{[2
]}

Shedeck, Audra ^{[2
]}

Baker, Julie ^{[2
]}

Imus, Philip Hollingsworth ^{[2
]}

Wagner-Johnston, Nina ^{[2
]}

Jain, Tania ^{[2
,3
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[2] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Hematol Malignancies & Bone Marrow Transplanta, Baltimore, MD USA

[3] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Hematol Malignancies & Bone Marrow Transplanta, 1650 Orleans St,Room 3M88, Baltimore, MD 21287 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 203卷 / 04期

关键词：

D O I：

10.1111/bjh.19090

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：688 / 692

页数：5

共 50 条

[31] CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma
Pophali, Priyanka A.
Fein, Joshua A.
Ahn, Kwang W.
Allbee-Johnson, Molly
Ahmed, Nausheen
Awan, Farrukh T.
Farhan, Shatha
Grover, Natalie S.
Hilal, Talal
Iqbal, Madiha
Maakaron, Joseph
Modi, Dipenkumar
Nasrollahi, Elham
Schachter, Levanto G.
Sauter, Craig
Hamadani, Mehdi
Herrera, Alex
Shouval, Roni
Shadman, Mazyar
BLOOD ADVANCES, 2024, 8 (20) : 5290 - 5296
[32] Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis
Kaulen, Leon D.
Karschnia, Philipp
Doubrovinskaia, Sofia
Abramson, Jeremy S.
Martinez-Lage, Maria
Shankar, Ganesh
Choi, Bryan D.
Barnes, Jeffrey A.
El-Jawahri, Areej
Hochberg, Ephraim P.
Johnson, P. Connor
Soumerai, Jacob D.
Wick, Wolfgang
Maus, Marcela V.
Chen, Yi-Bin
Frigault, Matthew J.
Dietrich, Jorg
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (12) : 2411 - 2415
[33] Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
Schubert, Maria-Luisa
Schmitt, Anita
Hueckelhoven-Krauss, Angela
Neuber, Brigitte
Kunz, Alexander
Waldhoff, Philip
Vonficht, Dominik
Yousefian, Schayan
Jopp-Saile, Lea
Wang, Lei
Korell, Felix
Keib, Anna
Michels, Birgit
Haas, Dominik
Sauer, Tim
Derigs, Patrick
Kulozik, Andreas
Kunz, Joachim
Pavel, Petra
Laier, Sascha
Wuchter, Patrick
Schmier, Johann
Bug, Gesine
Lang, Fabian
Goekbuget, Nicola
Casper, Jochen
Goerner, Martin
Finke, Juergen
Neubauer, Andreas
Ringhoffer, Mark
Wolleschak, Denise
Brueggemann, Monika
Haas, Simon
Ho, Anthony D.
Mueller-Tidow, Carsten
Dreger, Peter
Schmitt, Michael
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
[34] Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
Maria-Luisa Schubert
Anita Schmitt
Angela Hückelhoven-Krauss
Brigitte Neuber
Alexander Kunz
Philip Waldhoff
Dominik Vonficht
Schayan Yousefian
Lea Jopp-Saile
Lei Wang
Felix Korell
Anna Keib
Birgit Michels
Dominik Haas
Tim Sauer
Patrick Derigs
Andreas Kulozik
Joachim Kunz
Petra Pavel
Sascha Laier
Patrick Wuchter
Johann Schmier
Gesine Bug
Fabian Lang
Nicola Gökbuget
Jochen Casper
Martin Görner
Jürgen Finke
Andreas Neubauer
Mark Ringhoffer
Denise Wolleschak
Monika Brüggemann
Simon Haas
Anthony D. Ho
Carsten Müller-Tidow
Peter Dreger
Michael Schmitt
Journal of Hematology & Oncology, 16
[35] CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD
Cabrera-Maqueda, Jose Maria
Sepulveda, Maria
Garcia, Raquel Ruiz
Munoz-Sanchez, Guillermo
Martinez-Cibrian, Nuria
Ortiz-Maldonado, Valentin
Lorca-Arce, Daniel
Guasp, Mar
Llufriu, Sara
Martinez-Hernandez, Eugenia
Armangue, Thais
Fonseca, Elianet G.
Alba-Isasi, Maria Teresa
Delgado, Julio
Dalmau, Josep
Juan, Manel
Saiz, Albert
Blanco, Yolanda
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (05):
[36] CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells
Storci, Gianluca
De Felice, Francesco
Ricci, Francesca
Santi, Spartaco
Messelodi, Daria
Bertuccio, Salvatore Nicola
Laprovitera, Noemi
Dicataldo, Michele
Rossini, Lucrezia
De Matteis, Serena
Casadei, Beatrice
Vaglio, Francesca
Ursi, Margherita
Barbato, Francesco
Roberto, Marcello
Guarino, Maria
Asioli, Gian Maria
Arpinati, Mario
Cortelli, Pietro
Maffini, Enrico
Tomassini, Enrica
Tassoni, Marta
Cavallo, Carola
Iannotta, Francesco
Naddeo, Maria
Tazzari, Pier Luigi
Dan, Elisa
Pellegrini, Cinzia
Guadagnuolo, Serafina
Carella, Matteo
Sinigaglia, Barbara
Pirazzini, Chiara
Severi, Caterina
Garagnani, Paolo
Kwiatkowska, Katarzyna Malgorzata
Ferracin, Manuela
Zinzani, Pier Luigi
Bonafe, Massimiliano
Bonifazi, Francesca
JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (14):
[37] Recurrent urinary tract infections and low secretory IgA following CD19-directed CAR T-cell therapy for relapsed acute lymphoblastic leukemia
McGraw, Bettina Isaac
Sweeney, Colleen
Savasan, Suereyya
PEDIATRIC BLOOD & CANCER, 2018, 65 (01)
[38] Phase I Study of a CD19-Directed CAR-T Cell Therapy for Relapsed/Refractory Mantle Cell Lymphomas(MCL)
Yang, Ping
Liu, Shuozi
Zhang, Weilong
Wang, Jing
Jing, Hongmei
BLOOD, 2023, 142
[39] Hypoimmune, Allogeneic CD22-Directed CAR T Cells That Evade Innate and Adaptive Immune Rejection for the Treatment of Large B Cell Lymphoma Patients That Are Relapsed/Refractory to CD19-Directed CAR T Cell Therapy
Johnson, Adam
Wright, Hallee
Hu, Xiaomeng
Kinder, Jeremy
van Hoeven, Neal
Liang, Ouwen
Granger, Brian
Duback, Tori
Baldeviano, Chris
Chandra, Sundeep
McGill, Trevor
Gorovits, Boris
Joyce, Shannon
Crocker, Sam
Liang, Anna
Rocca, Carrie
Migliaccio, Jenny
Kumar, Prasanna
Vagin, Vasily
Enger, Kerrie
Young, Chi
McAlister, Andrew
Schrepfer, Sonja
Fry, Terry J.
BLOOD, 2023, 142
[40] CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy (vol 4, pg 3850, 2020)
Thapa, B.
Caimi, P. F.
Ardeshna, K. M.
Carlo-Stella, Carmelo
BLOOD ADVANCES, 2020, 4 (19) : 4606 - 4606

← 1 2 3 4 5 →